Zepbound is the new weight loss medication from Eli Lilly. Patients are losing on average 20% of their body weight in just over a year. Simply amazing.
Stick around to the end to quiz yourself on what you learned!
If you're considering Zepbound for weight loss, this video series is for you. In this second video, we discuss the indications for GLP-1 medications, specifically Zepbound, and who should NOT take the medication.
There are a number of medical conditions that preclude patients from using GLP-1 medications. Learn about them before you consider starting on this therapy. There's more out there than Ozempic!
Follow this video series to learn more. Emerge is a telehealth Obesity Management and Urgent Care medical practice. www.emergefor.me/
Check out our Facebook group to support your weight loss journey! / 543288764320370
#zepbound #weightloss #emergeforme #mounjaro #semaglutide #wegovy #ozempic #glp1 #glp1medication #weightlosstransformation #2024